When administering albuterol, which adverse reaction should the nurse closely monitor?

Albuterol is a beta-2 adrenergic agonist commonly used as a bronchodilator for patients with conditions like asthma and chronic obstructive pulmonary disease (COPD). One of the known adverse reactions associated with the use of albuterol is tremors. This occurs due to the stimulation of beta-2 receptors not only in the respiratory tract but also in skeletal muscle, leading to muscle tremors.

Monitoring for tremors is essential because while they may be benign, they can also indicate increasing doses of albuterol or sensitivity to the medication. Some patients may experience significant tremors that can interfere with daily activities and create discomfort.

While the other adverse reactions, such as bradycardia, nausea, and headache, can occur, they are not as commonly associated with albuterol as tremors. Bradycardia, in particular, is unlikely since beta-2 agonists tend to cause tachycardia rather than bradycardia. Therefore, the focus on tremors as a significant and common adverse effect of albuterol administration is warranted for effective patient monitoring and management.